Learn more

CUATRECASAS LABOR M

Overview
  • Total Patents
    31
About

CUATRECASAS LABOR M has a total of 31 patent applications. Its first patent ever was published in 1955. It filed its patents most often in Spain, Germany and France. Its main competitors in its focus markets pharmaceuticals and environmental technology are NEUTRON ROW, FIDES LAB and SOLVAY PHARMA.

Patent filings in countries

World map showing CUATRECASAS LABOR Ms patent filings in countries
# Country Total Patents
#1 Spain 27
#2 Germany 1
#3 France 1
#4 United Kingdom 1
#5 Italy 1

Patent filings per year

Chart showing CUATRECASAS LABOR Ms patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Llobet Pere Puigdellivol 3
#2 Baylina Elisa Goday 3
#3 Goday Baylina Elisa 1
#4 Puigdellivol Llobet Pere 1

Latest patents

Publication Filing date Title
ES8402817A1 Therapeutic 1-(acylamino)-naphthalene-4-sulphonic acid derivatives
ES8305697A1 N-4-hydroxyphenyl acetamide derivs. prepn.
ES8302651A1 Procedure for obtaining derivatives of 1,7-dihydropyrane (4,3-b) pirrol-4,6-diona with analgesic activity. (Machine-translation by Google Translate, not legally binding)
ES511298A0 PROCEDURE FOR OBTAINING SALTS OF COMPOUNDS WITH CARDIOVASCULAR ACTIVITY.
ES509310A0 PROCEDURE FOR THE OBTAINING OF NEW THERAPEUTICALLY ACTIVE SALTS OF ARIL SULPHONIC ACIDS.
ES8201994A1 Procedure for the obtaining of new piridinic derivatives of pharmacological interest (Machine-translation by Google Translate, not legally binding)
ES492682A0 PROCEDURE FOR THE PREPARATION OF 4'-HYDROXY-KETOPHENONE DERIVATIVES OF PHARMACOLOGICAL INTEREST
ES8103080A1 Procedure for obtaining an alcaloid derivative of pharmacological interest (Machine-translation by Google Translate, not legally binding)
ES480874A1 Procedure for the obtaining of an N-substituted aminoacido of pharmacological interest. (Machine-translation by Google Translate, not legally binding)
ES470902A1 Procedure for the obtaining of a new cephalosporanic derivative. (Machine-translation by Google Translate, not legally binding)
ES464943A1 Procedure for the obtaining of amidas of pharmacological interest. (Machine-translation by Google Translate, not legally binding)
ES464944A1 Procedure for the obtaining of s-cycles of pharmacological interest. (Machine-translation by Google Translate, not legally binding)
ES458005A1 Procedure for the obtaining of new salts of cephalosporine antibiotics. (Machine-translation by Google Translate, not legally binding)
ES458004A1 Procedure for the obtaining of new salts of cephalosporanic derivatives. (Machine-translation by Google Translate, not legally binding)
ES458006A1 Procedure for the obtaining of new cefalosporanic derivatives. (Machine-translation by Google Translate, not legally binding)
ES452885A1 Procedure for the obtaining of new salts of 2,4-diamino-5- (3,4,5-trimetoxibencil) -pirimidina insolubles in aqueous media. (Machine-translation by Google Translate, not legally binding)
ES439066A1 Procedure for obtaining alkaline salts from 4-hydroxyburic acid. (Machine-translation by Google Translate, not legally binding)
ES438367A1 Procedure for the obtaining of products of condensation of phenolic derivatives with N-substituted azetidinols of pharmacological interest. (Machine-translation by Google Translate, not legally binding)
ES397445A1 Procedure for the obtaining of hexahidrometano-benzazo-cinoles-N-alilicos. (Machine-translation by Google Translate, not legally binding)
ES376943A1 Procedure for obtaining an orexygen product. (Machine-translation by Google Translate, not legally binding)